Senolytic therapy targeting cellular senescence and zombie cells in aging tissue | Healthcare Discovery
| | |

Zombie Cells Meet Their Match: How Natural Fatty Acids Could Become Longevity’s Most Promising New Weapon

Researchers at the University of Minnesota have identified naturally occurring fatty acids, specifically alpha-eleostearic acid and its methyl ester derivative, that selectively kill senescent zombie cells through ferroptosis. Published in…

Immune cells clearing damaged mitochondria through mitophagy as urolithin A supports immune rejuvenation
| | |

Your Thymus Didn’t Retire: Two Nature Studies Show This Overlooked Organ Predicts 50% Lower Death Risk

Two papers published in Nature in March 2026 used AI-powered CT analysis across 27,000 adults to show that thymic health predicts 50% lower all-cause mortality, 63% lower cardiovascular death, and…

Organ biological age blood proteins longevity research | Healthcare Discovery
| | | |

Your Organs Are Not Aging at the Same Rate: What 2,916 Blood Proteins Reveal About Your Longevity Clock

A Nature Medicine study of 44,498 people used 2,916 blood proteins to measure the biological age of 11 separate organs, finding that a biologically young brain and immune system together…

Phosphatidylcholine mitochondria aging research in longevity laboratory | Healthcare Discovery
| | |

New Science Study: Half Your Lifespan Is Genetic, Doubling Previous Estimates

A landmark 2026 Science study from the Weizmann Institute finds lifespan is roughly 50% heritable — more than double previous estimates. Inside the methodology, what it means for longevity research,…

Senolytic therapy targeting senescent zombie cells in aging tissue during 2026 longevity clinical trials
| | |

Senolytics in 2026: Inside the Clinical Trials Targeting Zombie Cells to Extend Healthy Lifespan

More than 30 senolytic and senomorphic clinical trials are now active, spanning diabetic macular edema, pulmonary fibrosis, osteoarthritis, and frailty. Inside the science of zombie cells, the first-generation compounds from…

The Healthtech Intelligence Report | Healthcare Discovery
| | |

Mitochondrial Transplantation Enters Human Trials: How Moving Living Powerhouses Between Cells Is Rewriting Longevity Medicine

Mitochondrial transplantation, once a fringe idea, is now being tested in human clinical trials for heart failure, stroke, and age-related cellular decline. A new wave of 2026 research shows that…

Healthtech Wearables Intelligence Report covering 257 devices across 17 categories | Healthcare Discovery
| |

myDNAge Epigenetic Clock: The Original Horvath Clock Made Consumer-Accessible

Built by the epigenetics company behind the gold-standard research reagents, myDNAge brings Steve Horvath’s original epigenetic clock directly to consumers, with the unique option of testing from a urine sample….

Healthtech Wearables Intelligence Report covering 257 devices across 17 categories | Healthcare Discovery
| |

Chronomics Epigenetic Testing: Longitudinal Biological Age Tracking and Lifestyle Impact Measurement

Designed for repeat testing rather than one-time snapshots, Chronomics measures biological age through DNA methylation with a focus on tracking how lifestyle changes move the needle over time. The most…

Healthtech Wearables Intelligence Report covering 257 devices across 17 categories | Healthcare Discovery
| |

GeneSight Pharmacogenomics: How Genetic Testing Is Changing Psychiatric Medication Selection

For the millions of patients who cycle through antidepressant after antidepressant without relief, GeneSight offers a genetic map of how their body metabolizes psychiatric medications. The science of pharmacogenomics is…